A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study. - Bae-Jump, Victoria L.; Sill, Michael W.; Gehrig, Paola A.; Merker, Jason D.; Corcoran, David L.; Pfefferle, Adam D.; Hayward, Michele C.; Walker, Joan L.; Hagemann, Andrea R.; Waggoner, Steven E.; O'Cearbhaill, Roisin E.; McDonald, Megan E.; et al. (Gynecologic Oncology, 2025)